ProShare Advisors LLC Raises Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC)
ProShare Advisors LLC boosted its holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 19.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 75,252 shares of the biopharmaceutical company’s stock after buying an additional 12,155 shares during the quarter. ProShare Advisors LLC’s […]
ProShare Advisors LLC boosted its holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 19.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 75,252 shares of the biopharmaceutical company’s stock after buying an additional 12,155 shares during the quarter. ProShare Advisors LLC’s […]
